8.19
前日終値:
$8.09
開ける:
$8.15
24時間の取引高:
911.65K
Relative Volume:
0.70
時価総額:
$1.06B
収益:
$175.51M
当期純損益:
$-78.02M
株価収益率:
-15.45
EPS:
-0.53
ネットキャッシュフロー:
$-34.18M
1週間 パフォーマンス:
+4.46%
1か月 パフォーマンス:
+0.86%
6か月 パフォーマンス:
-8.29%
1年 パフォーマンス:
+51.95%
Aurinia Pharmaceuticals Inc Stock (AUPH) Company Profile
名前
Aurinia Pharmaceuticals Inc
セクター
電話
250-744-2487
住所
#140, 14315 - 118 AVENUE, EDMONTON, BC
AUPH を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
AUPH
Aurinia Pharmaceuticals Inc
|
8.19 | 1.06B | 175.51M | -78.02M | -34.18M | -0.53 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
450.50 | 113.52B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
493.22 | 52.93B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
300.83 | 39.71B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
585.93 | 35.00B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
255.86 | 26.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Aurinia Pharmaceuticals Inc Stock (AUPH) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2022-11-04 | ダウングレード | Oppenheimer | Outperform → Perform |
2022-05-05 | 再開されました | Cantor Fitzgerald | Overweight |
2021-12-10 | アップグレード | Oppenheimer | Perform → Outperform |
2021-10-28 | ダウングレード | Oppenheimer | Outperform → Perform |
2021-01-25 | 繰り返されました | H.C. Wainwright | Buy |
2020-11-03 | 繰り返されました | H.C. Wainwright | Buy |
2020-06-17 | 開始されました | BTIG Research | Buy |
2020-05-05 | 開始されました | Cowen | Outperform |
2020-01-10 | 開始されました | Jefferies | Buy |
2019-12-16 | 繰り返されました | H.C. Wainwright | Buy |
2018-03-16 | 繰り返されました | Cantor Fitzgerald | Overweight |
2018-02-08 | 開始されました | RBC Capital Mkts | Outperform |
2017-10-30 | 繰り返されました | H.C. Wainwright | Buy |
2017-05-18 | 繰り返されました | H.C. Wainwright | Buy |
2017-04-11 | 開始されました | Cantor Fitzgerald | Overweight |
2017-03-22 | 繰り返されました | FBR & Co. | Outperform |
2016-12-30 | 繰り返されました | H.C. Wainwright | Buy |
2016-08-17 | 繰り返されました | H.C. Wainwright | Buy |
2016-06-30 | 開始されました | H.C. Wainwright | Buy |
2015-05-08 | 開始されました | MLV & Co | Buy |
すべてを表示
Aurinia Pharmaceuticals Inc (AUPH) 最新ニュース
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SDIG, AUPH and LICY - ACCESS Newswire
(AUPH) Trading Signals - news.stocktradersdaily.com
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $3.27 Million Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - InsuranceNewsNet
Ameriprise Financial Inc. Acquires 26,981 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of AUPH, IRNT and RSKD - ACCESS Newswire
Is the Options Market Predicting a Spike in Aurinia Pharmaceuticals (AUPH) Stock? - MSN
BNP Paribas Financial Markets Sells 14,003 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World
Is The Options Market Predicting A Spike In Aurinia Pharmaceuticals (AUPH) Stock? - Barchart.com
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Shares Purchased by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World
Nuveen Asset Management LLC Increases Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World
Cetera Investment Advisers Purchases 2,000 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World
(AUPH) Technical Data - news.stocktradersdaily.com
Deutsche Bank AG Purchases 50,575 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World
Aurinia Pharmaceuticals (AUPH) Reports Positive Lupkinis Trial R - GuruFocus
Aurinia Pharmaceuticals (AUPH) Reports Positive Lupkinis Trial Results | AUPH Stock News - GuruFocus
Aurinia Pharmaceuticals’ LUPKYNIS Shows Promising Results in Lupus Nephritis Study - TipRanks
Aurinia Pharmaceuticals' (NASDAQ:AUPH) Strong Earnings Are Of Good Quality - simplywall.st
Aurinia Pharmaceuticals' (NASDAQ:AUPH) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance
Aurinia Pharmaceuticals Inc. Just Recorded A 60% EPS Beat: Here's What Analysts Are Forecasting Next - Yahoo Finance
Leerink Partnrs Has Positive Outlook of AUPH Q2 Earnings - Defense World
Aurinia Pharmaceuticals Approves New Equity Incentive Plan - TipRanks
Aurinia Pharmaceuticals Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - simplywall.st
Aurinia Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Transcript : Aurinia Pharmaceuticals Inc.Shareholder/Analyst Call - marketscreener.com
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2025 Earnings Call Transcript - MSN
Aurinia Pharmaceuticals Financial Update and Strategic Growth Plans - Zenopa
Aurinia Pharmaceuticals (AUPH) Reports Strong Q1 Earnings Beat - GuruFocus
Price T Rowe Associates Inc. MD Has $468,000 Stock Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World
Aurinia outlines $250M–$260M 2025 revenue target as LUPKYNIS sales climb 25% and operational efficiency improves - MSN
Decoding Aurinia Pharmaceuticals Inc (AUPH): A Strategic SWOT In - GuruFocus
Aurinia Pharmaceuticals Reports Strong Q1 2025 Earnings - TipRanks
Document - SEC.gov
Aurinia Pharmaceuticals Q1 2025 Earnings: Strong Growth Amid Challenges - TipRanks
Aurinia: Q1 Earnings Snapshot - MySA
Aurinia Pharmaceuticals Q1 2025 Earnings Call Transcript - MarketBeat
Aurinia Pharma Swings Into Profit As Q1 Sales Jumps 24%, Sticks To Guidance - Benzinga
Leerink maintains Aurinia stock Outperform with $10 target - Investing.com
Aurinia Stock Rallies On Upbeat Q1 Earnings, CEO Expects Strong Performance in 2025: Retail Sentiment Brightens - Investing.com India
AUPH Reports Q1 Revenue Exceeding Expectations with Strong Outlo - GuruFocus
Aurinia Pharmaceuticals (AUPH) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance
Aurinia Pharmaceuticals' Q1 Swings to Profit, Revenue Rises; Reiterates 2025 Revenue Guidance - marketscreener.com
Aurinia Pharmaceuticals Inc. SEC 10-Q Report - TradingView
Aurinia Pharmaceuticals Inc. Reiterates Guidance for the Full Year 2025 - marketscreener.com
Aurinia Pharmaceuticals Reports Strong First Quarter 2025 Financial Results - TipRanks
Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025 - Business Wire
Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) CEO Will Probably Find It Hard To See A Huge Raise This Year - simplywall.st
How the (AUPH) price action is used to our Advantage - news.stocktradersdaily.com
Aurinia Pharmaceuticals to Release First Quarter 2025 Financial and Operational Results on May 12, 2025 - BioSpace
Invesco Ltd. Acquires 1,421 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World
Aurinia Pharmaceuticals Inc (AUPH) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):